01 · THE CUSTOMER PROBLEM
Medical-textile teams need to move chitosan functionality into a fiber that survives real converting, sterilization and wound-contact requirements.
Mykito connects molecular specification to continuous filament, staple, yarn and nonwoven formats so the material can enter an existing textile workflow.
Chitosan fibers, yarns and nonwoven structures for absorbable, wound-contact and regenerative medical-device development.
02 · RECOMMENDED STARTING POINT
Start with the material designed for the decision.
Transforming chitosan into a continuous fiber moves its biological and surface properties into a scalable textile format that can be cut, layered, woven, knitted or formed into a nonwoven.
Without the shell
Controlled fungal sourcing supports a traceable, non-animal supply strategy.
Specification engineered
MW, DDA, purity, charge density and format are selected around the target result.
Application ready
Powder is only the starting point; Mykito also develops films, fibers, gels, coatings and formulations.
One technical partner
Material selection, formulation support and the validation plan are connected from the first sample.
03 · PERFORMANCE TARGETS
Build toward outcomes a buyer can measure.
Wound-contact textiles
Wound-contact textiles can be developed by matching the chitosan specification, dose and application-ready format to the finished medical fibers + nonwovens system.
Absorbable structures
Absorbable structures can be developed by matching the chitosan specification, dose and application-ready format to the finished medical fibers + nonwovens system.
Biofunctional nonwovens
Biofunctional nonwovens can be developed by matching the chitosan specification, dose and application-ready format to the finished medical fibers + nonwovens system.
04 · GO / NO-GO CRITERIA
Define the evidence before testing begins.
The first program is designed around three decision-making outputs—not an open-ended material trial.
Fiber strength and converting performance
Absorbency and wet integrity
Sterilization and biocompatibility
05 · FROM SAMPLE TO DECISION
A practical application program,
not a bag of powder.
Define
Agree on the function, baseline, constraints and measurable success criteria.
Screen
Select the MW, DDA, purity, dose and physical format that fit the application.
Validate
Test the winning system in the finished formulation, device, process or use environment.
Recommended first request: A fiber or nonwoven sample matched to the intended textile process and contact classification.
Start the Sample Brief06 · WHY CHITOSAN
A functional tissue interface
Coatings, fibers, films, gels and porous matrices can create a modifiable interface on metals, polymers, composites or wound-contact structures.
There is no universal concentration. Grade and dose are screened against pH, interacting ingredients, process conditions and the target performance profile.
Biocompatibility, endotoxin, sterilization, mechanics and degradation are qualified around the final device and contact classification.